Phoenix Biotech Acquisition Corp. (PBAXW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 24.74M |
| Enterprise Value | 23.78M |
| P/E Ratio | -0.27 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -8.09 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -14.62 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -50.16 |
| Return On Equity | 7.66 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 1.09M |
| Net Income | -95.53M |
| Diluted EPS | -22.58 |
Balance Sheet
| Total Cash | 937,512 |
| Total Cash/Share | 0.02 |
| Total Debt | 8.63M |
| Total Debt/Equity | -0.28 |
| Current Ratio | 0.05 |
| Book Value Per Share | -0.72 |
Price History
| 52-Week Change | 60 |
| 52-Week High | 0.06 |
| 52-Week Low | 0.05 |
| Moving Average 50 Days | 0 |
| Moving Average 200 Days | 0 |
Statistics
| Average Volume | 0 |
| Shares Outstanding | 6.26M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
